Skip to main content
FinSpry Logo
FinSpry
OBIO logo
OBIO
(NASDAQ)
Orchestra BioMed Holdings, Inc.
$4.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Orchestra BioMed Holdings (OBIO) Stock Price & Financial Analysis

Orchestra BioMed Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.09 - $4.39
52-Week High$5.42
52-Week Low$2.20
Open$4.25
Volume139.84K
Average Volume (3M)139.84K
Market Cap163.94M
Shares Outstanding38.39M
Price to Sales (P/S)4.98
Price to Book (P/B)3.11
EV/EBITDA-2.59
Revenue (TTM)33.48M
Net Income (TTM)-52.95M
Free Cash Flow (TTM)-49.45M
EPS (TTM)$-1.38
Profit Margin-158.16%
Operating Margin-154.73%
Return on Equity (ROE)-98.85%
Debt to Equity0.03
50-Day MA$4.22
200-Day MA$3.65
52-Week Change33.95%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Orchestra BioMed Holdings

What is the current stock price for OBIO?

As of the latest trading session, OBIO stock trades at $4.27. The 52-week range is $2.20–$5.42, with a day range of $4.09–$4.39.

What is the P/E ratio for OBIO?

The P/E ratio (Price-to-Earnings) for OBIO is shown in the Key Statistics section. This valuation metric helps compare Orchestra BioMed Holdings, Inc. to industry peers.

Does OBIO pay dividends?

Orchestra BioMed Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OBIO?

Based on 2 analysts, the consensus for OBIO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OBIO?

Orchestra BioMed Holdings's market capitalization is $163.9M, classifying it as a micro-cap company. Orchestra BioMed Holdings operates in the Healthcare sector within the Biotechnology industry.